1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TMSB15A CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA SUGP2 CTRPv2 pan-cancer AAC 0.22 6e-09
mRNA CENPV CTRPv2 pan-cancer AAC 0.21 6e-09
mRNA RAD54L2 CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA LDOC1L CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA DENND6A CTRPv2 pan-cancer AAC 0.19 8e-09
mRNA PAXBP1 CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA ATXN7L2 CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA KLHL23 CTRPv2 pan-cancer AAC 0.21 9e-09
mRNA TIA1 CTRPv2 pan-cancer AAC 0.19 9e-09
Download CSV